# Brown Biotech Daily Tech Digest — 2026-10-18 > 매일 아침 AI·바이오텍·펩타이드 시장 시그널을 수집하고, > Brown Biotech 파이프라인 관점에서 decision-ready 인사이트로 정리합니다. ## 🔬 Today's Top Signals ### 1. GLP-1 may slow biological aging **Source:** HN Algolia (50132328) · **Score:** 4/8 Peptide-aging crossover extends GLP-1 TAM beyond weight-loss. ### 2. GLP-1 Drugs Cut Schizophrenia Hospital Visits, Study Finds **Source:** HN Algolia (50096849) · **Score:** 4/8 Neuropsychiatric GLP-1 widens peptide demand to schizophrenia populations. ### 3. AI coding agents generate more code, but not more software **Source:** HN Algolia (50059523) · **Score:** 4/8 Productivity-plateau study challenges biostatx agent value-add thesis. ### 4. Launch HN: Agent37 (YC F26) – Low-cost agent sandboxes for running agents **Source:** HN Algolia (50059096) · **Score:** 4/8 YC F26 sandbox launch validates biostatx local-first runtime. ### 5. Show HN: rStation – A shared research lab for your AI agents **Source:** HN Algolia (50118876) · **Score:** 4/8 Multi-agent research lab fits biostatx biotech workflows. ## 💡 Brown Biotech Insights - *peptide-service*: GLP-1 aging + schizophrenia widen peptide TAM; CDMO positioning holds. - *biostatx*: Agent37 + rStation validate local-first sandbox thesis; YC F26 batch. - *genox-site*: productivity-plateau study reinforces platform-neutral evidence pipeline. - *business-pipeline*: monitor YC F26 for next vertical peptide play. ## 🎯 Next Action Share Agent37 + rStation launch posts with biostatx team for sandbox-runtime benchmark. --- _Published 2026-10-18 07:04 KST · [brownbio.tech](https://brownbio.tech) · Source: Hacker News, GeekNews, Reddit ML/bioinformatics, Science Immunology_
2026-10-18